Position in RLMD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$496,198
-$2,868 QoQ
Shares Held
71,705
0.0% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#71
of 126 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANGROVE PARTNERS IM, LLC holds $8,126,934 across 17 Biotechnology names. RLMD ranks #8 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,916 | $1,160,866 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
47,927 | $1,064,458 | |
| 3 | ALT |
Altimmune, Inc.
|
239,280 | $727,411 | |
| 4 | 33,346 | $708,602 | |||
| 5 | ARVN |
Arvinas, Inc.
|
76,220 | $633,388 | |
| 6 | LENZ |
LENZ Therapeutics, Inc.
|
96,749 | $549,534 | |
| 7 | SLS |
SELLAS Life Sciences Group, Inc.
|
34,140 | $503,906 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
This page
|
71,705 | $496,198 |
All Filings in RLMD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,198 | 71,705 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $499,066 | 71,705 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $132,245 | 27,380 | Shares | Sole | 2026-02-17 | |
| 2022-03-31 | $6,965,957 | 258,094 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,998,607 | 133,094 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,171,793 | 159,168 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,503,701 | 46,976 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||